Nalbuphine Versus Morphine for Perioperative Tumor Ablation
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
This randomized, positive control, multicentre trial is designed to compare the analgesic
efficacy and safety of nalbuphine hydrochloride injection and morphine hydrochloride
injection for perioperative tumor ablation.